State Street SPDR S&P Pharmaceuticals ETF XPH
Set alert
64.96 USD +1.19 +1.87%
As of Nov 3, 9:53 AM ET
64.21 Day range 65.01
47.60 52-week range 74.35
- YTD
- +15.98%
- 1 year
- +30.70%
- Open
- 64.03
- Prev close
- 63.77
- Mkt cap
- 256.53M
- Vol
- 30.74K
- Avg vol
- 177.87K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 64.21
- High
- 65.01
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 45.94
- 200-d avg
- 42.92
2Y chart
Events in this range
- Dec 23, 2024Dividend: 0.15484
- Mar 24, 2025Dividend: 0.15332
- Jun 23, 2025Dividend: 0.095872
- Sep 22, 2025Dividend: 0.10263
- Dec 22, 2025Dividend: 0.11302
- Mar 23, 2026Dividend: 0.060954
- Jun 22, 2026Dividend: 0.059045
- Sep 21, 2026Dividend: 0.04164
Signals (70)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 5 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
Newest 20 of 70.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 15.63
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 45.94
- 200-day average
- 42.92
About State Street SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Why Is Organon Stock Skyrocketing Monday?
- Why Is Amneal Pharmaceuticals Stock Gaining Today?
- Axsome Stock Climbs On Schizophrenia Drug Deal With Takeda
- Prestige Bets $1 Billion On World's Most Iconic Nasal Strip
- Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
- Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
- Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Your note
Sign in to keep a note on XPH — it syncs with the Stock Master app.